178 related articles for article (PubMed ID: 25601427)
1. Human genetics of HDL: Insight into particle metabolism and function.
Brunham LR; Hayden MR
Prog Lipid Res; 2015 Apr; 58():14-25. PubMed ID: 25601427
[TBL] [Abstract][Full Text] [Related]
2. High-density lipoproteins in the prevention of cardiovascular disease: changing the paradigm.
Tuteja S; Rader DJ
Clin Pharmacol Ther; 2014 Jul; 96(1):48-56. PubMed ID: 24713591
[TBL] [Abstract][Full Text] [Related]
3. Beyond the genetics of HDL: why is HDL cholesterol inversely related to cardiovascular disease?
Kuivenhoven JA; Groen AK
Handb Exp Pharmacol; 2015; 224():285-300. PubMed ID: 25522992
[TBL] [Abstract][Full Text] [Related]
4. Inconsistencies in the genetic prediction of HDL cholesterol versus atherosclerosis.
Carlquist J; Anderson JL
Curr Opin Cardiol; 2007 Jul; 22(4):352-8. PubMed ID: 17556889
[TBL] [Abstract][Full Text] [Related]
5. Beginning to understand high-density lipoproteins.
Santos-Gallego CG; Badimon JJ; Rosenson RS
Endocrinol Metab Clin North Am; 2014 Dec; 43(4):913-47. PubMed ID: 25432389
[TBL] [Abstract][Full Text] [Related]
6. The value of HDL genetics.
Holleboom AG; Vergeer M; Hovingh GK; Kastelein JJ; Kuivenhoven JA
Curr Opin Lipidol; 2008 Aug; 19(4):385-94. PubMed ID: 18607186
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein A-II is a key regulatory factor of HDL metabolism as appears from studies with transgenic animals and clinical outcomes.
Maïga SF; Kalopissis AD; Chabert M
Biochimie; 2014 Jan; 96():56-66. PubMed ID: 24012775
[TBL] [Abstract][Full Text] [Related]
8. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
Hausenloy DJ; Yellon DM
Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
[TBL] [Abstract][Full Text] [Related]
9. HDL Cholesterol Efflux Capacity: Cardiovascular Risk Factor and Potential Therapeutic Target.
Bhatt A; Rohatgi A
Curr Atheroscler Rep; 2016 Jan; 18(1):2. PubMed ID: 26710794
[TBL] [Abstract][Full Text] [Related]
10. Mendelian disorders of high-density lipoprotein metabolism.
Oldoni F; Sinke RJ; Kuivenhoven JA
Circ Res; 2014 Jan; 114(1):124-42. PubMed ID: 24385507
[TBL] [Abstract][Full Text] [Related]
11. Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality.
Barylski M; Toth PP; Nikolic D; Banach M; Rizzo M; Montalto G
Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):453-61. PubMed ID: 24840270
[TBL] [Abstract][Full Text] [Related]
12. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
13. [HDL metabolism].
Genschel J; Schmidt HH
Z Gastroenterol; 2001 Apr; 39(4):321-7. PubMed ID: 11367981
[TBL] [Abstract][Full Text] [Related]
14. News on the genetics of lipoprotein metabolism and cardiovascular disease.
van de Sluis B; Kuivenhoven JA
Curr Opin Lipidol; 2013 Apr; 24(2):185-6. PubMed ID: 23481232
[No Abstract] [Full Text] [Related]
15. Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease.
Barter PJ; Kastelein JJ
J Am Coll Cardiol; 2006 Feb; 47(3):492-9. PubMed ID: 16458126
[TBL] [Abstract][Full Text] [Related]
16. Assessing the functional properties of high-density lipoproteins: an emerging concept in cardiovascular research.
Triolo M; Annema W; Dullaart RP; Tietge UJ
Biomark Med; 2013 Jun; 7(3):457-72. PubMed ID: 23734809
[TBL] [Abstract][Full Text] [Related]
17. HDL as a Causal Factor in Atherosclerosis: Insights from Human Genetics.
Brunham LR
Curr Atheroscler Rep; 2016 Dec; 18(12):71. PubMed ID: 27785680
[TBL] [Abstract][Full Text] [Related]
18. Dysfunctional HDL: from structure-function-relationships to biomarkers.
Riwanto M; Rohrer L; von Eckardstein A; Landmesser U
Handb Exp Pharmacol; 2015; 224():337-66. PubMed ID: 25522994
[TBL] [Abstract][Full Text] [Related]
19. HDL particle subpopulations: Focus on biological function.
Rached FH; Chapman MJ; Kontush A
Biofactors; 2015; 41(2):67-77. PubMed ID: 25809447
[TBL] [Abstract][Full Text] [Related]
20. HDL-C: role as a risk modifier.
Barter P
Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
